Front Biosci (Landmark Ed).;19(3):429 46
( f ) Food intake, ( g ) RER (effect of treatment F(1,10) = 6.34 p = 0.031), ( h ) energy expenditure (with ANCOVA using BW as covariate), ( i ) ambulatory activity and ( j ) body weight change of WT mice treated with VEH or acyl-GIP ( d - j , n = 6 per group
Here, some categories and what the science shows: Weight and appetite-related peptides These are the only peptides consistently shown to support meaningful fat loss: Semaglutide (Wegovy, Ozempic) Tirzepatide (Zepbound, Mounjaro) These medications are known as GLP-1 receptor agonists (tirzepatide also acts on GIP)
The anecdata seem to indicate that the mode of delivery, that is whether or not systemic or local, doesn't seem to matter that much
After a treatment period of 3 months, to test the effectiveness of treatment as part of usual clinical care, vitamin B12 levels, activity meter, and questionnaires were repeated